Concepedia

Disposition and Pharmacokinetics of the Antimigraine Drug, Rizatriptan, in Humans

Kamlesh P. Vyas, Rita A. Halpin, Leslie A. Geer, Joan D. Ellis, Lida Liu, Haiyung Cheng, C.M. Chavez-Eng, B.K. Matuszewski, Sándor Varga, Alexander R. Guiblin,

Drug Metabolism and Disposition · 2000 · 62 citations · 14 references

DOI

Concepts

References

14

LAGRAN program for area and moments in pharmacokinetic analysis

Mario L. Rocci, William J. Jusko · Computer Programs in Biomedicine · 1983 · 415 citations

, , +8

Oral Rizatriptan Versus Oral Sumatriptan: A Direct Comparative Study in the Acute Treatment of Migraine

Peer Tfelt‐Hansen, Judith Teall, Francisco Javier Rodríguez‐Gómez et al. · Headache The Journal of Head and Face Pain · 1998 · 194 citations

, , +14

Crossover Comparison of Rizatriptan 5 mg and 10 mg Versus Sumatriptan 25 mg and 50 mg in Migraine

Jerome Goldstein, Robert Ryan, Kaihong Jiang et al. · Headache The Journal of Head and Face Pain · 1998 · 165 citations

, , +17

A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks

Mark S. Kramer, Deborah Matzura‐Wolfe, A. Polis et al. · Neurology · 1998 · 147 citations

, , +10

Rizatriptan (MAXALT) for the Acute Treatment of Migraine and Migraine Recurrence. A Placebo‐Controlled, Outpatient Study

Judith Teall, Michael Tuchman, Neal R. Cutler et al. · Headache The Journal of Head and Face Pain · 1998 · 143 citations

, , +15